MAPK14 and Parkinson disease: Taken together with a recent report, which demonstrated a direct link after MPP+ treatment between p38 MAP kinase and ATF6α [12], these findings suggest critical roles for the ATF6α and PERK/eIF2α/ATF4 pathways as defense systems against PD-related neurotoxins.